Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- West Vancouver
- Most recent report
- 10-K, filed Oct 28, 2026
- Incorporated
- N/A
- Filings on record
- 324 filings
- On EDGAR
- CIK 1610820
- Fiscal year ends
- July
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 69
News 8 of 65
- 8-K Current report on a material event Jun 26, 2026
- 8-K Significant contract Jun 3, 2026
- 8-K Current report on a material event Mar 31, 2026
- 8-K Shareholder vote results Mar 9, 2026
- 8-K Other events Feb 20, 2026
- 8-K Significant contract Jan 15, 2026
- 8-K Current report on a material event Dec 29, 2025
- 8-K Current report on a material event Dec 1, 2025
Prospectuses and Registrations 8 of 36
- 424B5 Prospectus supplement for an offering Jun 2, 2026
- 25-NSE Notice that a security was delisted Feb 26, 2026
- 424B4 Final prospectus for an offering Jan 14, 2026
- FWP Free writing prospectus Dec 23, 2025
- S-1 Registration statement for an offering Dec 23, 2025
- S-8 Registration statement for an employee plan Aug 1, 2025
- 424B4 Final prospectus for an offering Jul 16, 2025
- FWP Free writing prospectus Jul 11, 2025
Proxies 8
- DEF 14A Proxy statement for a shareholder vote Feb 12, 2026
- DEFA14A Extra proxy material Jan 3, 2025
- DEF 14A Proxy statement for a shareholder vote Dec 17, 2024
- DEF 14A Proxy statement for a shareholder vote Jan 9, 2024
- DEF 14A Proxy statement for a shareholder vote Jul 26, 2023
- PRE 14A Preliminary proxy statement Jun 30, 2023
- DEF 14A Proxy statement for a shareholder vote Jan 17, 2023
- PRE 14A Preliminary proxy statement Jan 5, 2023
Ownership 8 of 55
- SCHEDULE 13G Large holder reported a passive stake Jan 23, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 7, 2025
- SCHEDULE 13G Large holder reported a passive stake Oct 10, 2025
- SCHEDULE 13G Large holder reported a passive stake Jul 28, 2025
- SCHEDULE 13G Large holder reported a passive stake Jul 22, 2025
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 21, 2025
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 13, 2025
- SCHEDULE 13G Large holder reported a passive stake May 1, 2025
Other 8 of 91
- EFFECT Notice that a registration became effective Jan 13, 2026
- S-1MEF Jan 13, 2026
- CERT Exchange certified a listing Jan 13, 2026
- 8-A12B Registration of a security for exchange listing Jan 13, 2026
- CORRESP Reply to SEC staff Jan 8, 2026
- CORRESP Reply to SEC staff Jan 8, 2026
- CORRESP Reply to SEC staff Jan 6, 2026
- CORRESP Reply to SEC staff Jan 6, 2026
Everything here comes from BriaCell Therapeutics Corp.'s own filings on SEC EDGAR. The filing list is rechecked every hour.